Poor correlation between reactive syphilis serology and human immunodeficiency virus testing among potential cornea donors [see comments] NLM AIDSLINE Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Poor correlation between reactive syphilis serology and human immunodeficiency virus testing among potential cornea donors [see comments]

Am J Ophthalmol. 1995 Jan;119(1):1-6. Unique Identifier : AIDSLINE MED/95126214
Goldberg MA; Laycock KA; Kinard S; Wang H; Pepose JS; Department of Ophthalmology and Visual Sciences, Washington; University School of Medicine, St. Louis, Missouri 63110.


Abstract: PURPOSE: The current practice in which eye banks screen cornea donors for syphilis is based mainly on the potential utility of positive syphilis serology as a surrogate marker for human immunodeficiency virus-1 (HIV-1) infection. We examined the correlation between positive syphilis and HIV-1 serologies within the potential cornea donor population. METHODS: We distributed a questionnaire to 94 eye banks in the United States regarding their rates of positive serology for syphilis and HIV-1 between Feb. 1 and July 30, 1992. We subsequently used the polymerase chain reaction for HIV-1 to further evaluate the whole blood of 21 rapid plasma reagin and fluorescent treponemal antibody-positive, HIV-1 enzyme-linked immunosorbent assay (ELISA)-negative cornea donors to determine whether these donors were infected with HIV-1 but were within a seronegative window for HIV-1 antibodies at their time of death. RESULTS: Of 8,932 donors screened, 103 (1.15%) had reactive screening for syphilis serology and 35 (0.39%) were HIV-1 seropositive. No donor with positive syphilis serology was also HIV-1 seropositive. Twelve of 31 donors who originally tested seropositive for syphilis by nontreponemal screening tests (Venereal Disease Research Laboratory or rapid plasma reagin tests) proved seronegative for syphilis when further tested with a treponemal test (FTA-ABS or microhemagglutination-Treponema pallidum), suggesting a high (38.7%) false-positive rate for the syphilis screening tests. Additionally, all 21 rapid plasma reagin and fluorescent-treponemal antibody-positive, HIV-1 ELISA-negative donors further tested were also negative for HIV-1 by the polymerase chain reaction. CONCLUSIONS: Among potential cornea donors, a population prescreened for identifiable HIV-1 risk factors, positive syphilis serology appears to be a poor marker for HIV-1 infection. The role of syphilis screening of potential cornea donors may need to be reevaluated.
Keywords: AIDS Serodiagnosis *Corneal Transplantation/IMMUNOLOGY DNA, Viral/ANALYSIS Enzyme-Linked Immunosorbent Assay Eye Banks Human HIV Antibodies/ANALYSIS HIV Infections/*DIAGNOSIS/PREVENTION & CONTROL/TRANSMISSION *HIV-1/GENETICS/IMMUNOLOGY Polymerase Chain Reaction Questionnaires Support, Non-U.S. Gov't Syphilis/*DIAGNOSIS/PREVENTION & CONTROL/TRANSMISSION Syphilis Serodiagnosis *Tissue Donors JOURNAL ARTICLEKWDaidsserodiagnosisKWDcornealtransplantation/immunologydna,viral/analysisenzyme-linkedimmunosorbentassayeyebankshumanhivantibodies/analysishivinfections/KWDdiagnosis/prevention&control/transmissionKWDhiv-1/genetics/immunologypolymerasechainreactionquestionnairessupport,non-uKWDsKWDgov'tsyphilis/KWDdiagnosis/prevention&control/transmissionsyphilisserodiagnosisKWDtissuedonorsjournalarticle
Comment in: Am J Ophthalmol 1995 Jan;119(1):93-5
950430
M9540320

Copyright © 1995 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .